申请人:Sandoz Pharm. Corp.
公开号:US04829081A1
公开(公告)日:1989-05-09
Compounds of the formula ##STR1## in which Y is ##STR2## X is O or S; Z is --CHOH--CH.sub.2 --CHOH--CH.sub.2 --COOH, an ester or salt thereof or the lactone thereof; and each of R.sup.1, R.sup.2 and R.sup.3 can be alkyl, cycloalkyl; or substituted or unsubstituted phenyl; and additionally R.sup.3 can be hydrogen, are obtained by a multi-step process and are useful in the treatment of atherosclerosis, e.g. sodium(E)-7-(4-phenyl-2-isopropyl-5-phenylthien-3-yl)-3,5-dihydroxyhept-6- enoate.
该公式的化合物为##STR1##,其中Y为##STR2##,X为O或S;Z为--CHOH--CH.sub.2 --CHOH--CH.sub.2 --COOH,其酯或盐或内酯;R.sup.1,R.sup.2和R.sup.3中的每一个可以是烷基,环烷基,或取代或未取代的苯基;另外,R.sup.3可以是氢。这些化合物通过多步骤得到,并且可用于动脉粥样硬化的治疗,例如,sodium(E)-7-(4-phenyl-2-isopropyl-5-phenylthien-3-yl)-3,5-dihydroxyhept-6-enoate。